DP-b99 / D-Pharm  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DP-b99 / D-Pharm
MACSI, NCT00893867 / 2009-012025-11: Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke

Terminated
3
446
US, Canada, Europe, RoW
DP-b99, Placebo
D-Pharm Ltd.
Acute Ischemic Stroke
04/12
04/12

Download Options